Or click one of the links below: CAIN457G22101 The purpose of this study is to determine the PK, safety and tolerability of multiple doses of intravenous (i.v.) secukinumab in pediatric participants with JPsA Investigator Melissa E Elder Status Accepting Candidates Ages 2 Years - 17 Years Sexes All SMART-JIA This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) medications to a second TNFi (active control) within a sequential multiple assignment Investigators Melissa E Elder, Leandra Woolnough Status Accepting Candidates Ages 2 Years - 17 Years Sexes All News and patient stories: Arthritis ARDS patients improve with experimental treatment June 30, 2026 JUPITER, Fla
If unopened medication is left on a counter for a few hours, it may remain viable
Edamame Pods (Steamed): Sometimes, simplicity is best
How to Use How to Use Apply a few drops to the face in the morning and evening
270 In pancreatic adenocarcinoma, XBP1s promotes angiogenesis through VEGF-independent mechanisms, further underscoring its capacity to sustain tumor vascularization and growth
Send questions or comments to [email protected]